dailiport 1 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
dailiport 0,5 mg
sandoz pharmaceuticals d.d., slovinsko - takrolimus - 59 - immunopraeparata
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - iné antineoplastické látky - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
bovaclox dc xtra intramamálna suspenzia
norbrook laboratories (ireland) ltd., Írsko - susp.
drycloxa-kel 1000 mg intramammárna suspenzia
kela laboratoria n.v., belgicko - susp.
kloxerate plus dc 250 mg/500 mg intramammárna suspenzia
zoetis Česká republika, Česká republika - intramam. susp.
noroclox dc xtra intramamálna suspenzia
norbrook laboratories (ireland) ltd., Írsko - intramam. susp.
orbenin dc 500 mg intramamálna suspenzia
zoetis Česká republika, Česká republika - susp.
orbenin extra dc 600 mg intramammárna suspenzia
zoetis Česká republika, Česká republika - susp.
amoksiklav 156,25 mg/5 ml
sandoz pharmaceuticals d.d., slovinsko - amoxicilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)